Omrane Amira, Krayem Latifa, Touil Imen, Romdhani Raja, Brahem Yosra, Boussoffara Leila, Knani Jalel, Khalfallah Taoufik, Boudawara Nadia
Department of Occupational Medicine, Teaching Hospital of Taher Sfar Mahdia, Tunisia.
Department of Medicine, Public Hospital Moknine, Monastir, Tunisia.
Med Lav. 2025 Apr 17;116(2):15786. doi: 10.23749/mdl.v116i2.15786.
This study aimed to investigate the impact of asthma on work productivity among adults receiving asthma therapy.
A cross-sectional study involving 101 asthmatic patients treated at the Pulmonology Department of University Hospital in Mahdia (Tunisia) who had been employed for at least six months was conducted over the course of a year. Recruited patients were asked to complete a self-administered questionnaire that consisted of the Simplified Medication Adherence Questionnaire (SMAQ), the Work Productivity and Activity Impairment (WPAI), and the Pichot questionnaire.
The study's participants had a sex ratio of 0.51 and a mean age of 44.1±13.2 years. Exposure to aerocontaminants was high among 64.4% of patients. The majority of the patients were treated with inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) (54.4%), and nearly half were classified as having moderate asthma. Our findings revealed significant challenges faced by these patients, with 62.4% experiencing poorly controlled or uncontrolled asthma. Additionally, 69.3% were non-adherent to treatment, and 71.3% reported worsening symptoms while at work. They worked an average of 38.3±16.4 hours per week. The impact of general health status on work productivity was measured at 3.3±2.5. Absenteeism and presenteeism rates were 4.2% and 33.1%, respectively, resulting in a productivity loss of 30.4%. Activity impairment was associated with factors such as gender, alcohol consumption, and uncontrolled asthma.
Addressing asthma control, working conditions, and mental health emerges as essential strategies to enhance workplace productivity. When evaluating the effectiveness of interventions among active asthmatic patients, presenteeism, absenteeism, and productivity loss should be considered.
本研究旨在调查哮喘对接受哮喘治疗的成年人工作效率的影响。
一项横断面研究在一年时间内对101名在马赫迪耶（突尼斯）大学医院肺病科接受治疗且已工作至少六个月的哮喘患者进行。招募的患者被要求完成一份自我管理问卷，该问卷包括简化药物依从性问卷（SMAQ）、工作效率和活动受损情况问卷（WPAI）以及皮肖特问卷。
该研究的参与者性别比为0.51，平均年龄为44.1±13.2岁。64.4%的患者暴露于空气污染物中。大多数患者接受吸入性糖皮质激素（ICS）和长效β受体激动剂（LABA）治疗（54.4%），近一半患者被归类为中度哮喘。我们的研究结果揭示了这些患者面临的重大挑战，62.4%的患者哮喘控制不佳或未得到控制。此外，69.3%的患者不坚持治疗，71.3%的患者报告在工作时症状加重。他们平均每周工作38.3±16.4小时。一般健康状况对工作效率的影响评分为3.3±2.5。缺勤率和出勤但工作效率低下率分别为4.2%和33.1%，导致生产力损失30.4%。活动受损与性别、饮酒和未控制的哮喘等因素有关。
解决哮喘控制、工作条件和心理健康问题是提高工作场所生产力的关键策略。在评估对活跃哮喘患者干预措施的有效性时，应考虑出勤但工作效率低下、缺勤和生产力损失情况。
